NDC 53877-108 – TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood

Anhydrous Citric Acid 2.99 g/1000mL; Trisodium Citrate Dihydrate 26.3 g/1000mL; Sodium Phosphate, Monobasic, Monohydrate 2.22 g/1000mL; Dextrose Monohydrate… · Solution · Intravenous

Human Prescription Drug

Product NDC53877-108

Product details

Brand name
TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood
Generic name
Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine
Labeler
Terumo Corporation
Dosage form
Solution
Route
Intravenous
Marketing category
NDA · BN820528
Marketed since
December 14, 2009
Listing expires
December 31, 2026
Pharmacologic class
Anti-coagulant; Anti-coagulant; Calculi Dissolution Agent; Calculi Dissolution Agent

Active ingredients

Uses, dosage, side effects and warnings for TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood →

Package NDC codes (1)

Package NDCDescriptionSince
53877-108-066 BLISTER PACK in 1 CASE (53877-108-06) / 4 BAG in 1 BLISTER PACK (53877-108-01) / 63 mL in 1 BAG (53877-108-02)Dec 14, 2009